SOS2 and non-small cell lung carcinoma: Xie et al. discovered that miR-148a-3p can induce the inhibition of the proliferation and EMT progression of NSCLC by down-regulating SOS2/MAPK/ERK signaling pathways (Xie et al., 2019).